These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

768 related articles for article (PubMed ID: 27669966)

  • 21. Random mutagenesis of BoNT/E Hc nanobody to construct a secondary phage-display library.
    Shahi B; Mousavi Gargari SL; Rasooli I; Rajabi Bazl M; Hoseinpoor R
    J Appl Microbiol; 2014 Aug; 117(2):528-36. PubMed ID: 24766494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development, Screening, and Validation of Camelid-Derived Nanobodies for Neuroscience Research.
    Gavira-O'Neill CE; Dong JX; Trimmer JS
    Curr Protoc Neurosci; 2020 Dec; 94(1):e107. PubMed ID: 33185319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Joining the in vitro immunization of alpaca lymphocytes and phage display: rapid and cost effective pipeline for sdAb synthesis.
    Comor L; Dolinska S; Bhide K; Pulzova L; Jiménez-Munguía I; Bencurova E; Flachbartova Z; Potocnakova L; Kanova E; Bhide M
    Microb Cell Fact; 2017 Jan; 16(1):13. PubMed ID: 28114943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selection of Functional Intracellular Nanobodies.
    Woods J
    SLAS Discov; 2019 Aug; 24(7):703-713. PubMed ID: 31173539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoreaction of a recombinant nanobody from camelid single domain antibody fragment with Acinetobacter baumannii.
    Payandeh Z; Rasooli I; Mousavi Gargari SL; Rajabi Bazl M; Ebrahimizadeh W
    Trans R Soc Trop Med Hyg; 2014 Feb; 108(2):92-8. PubMed ID: 24463583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural Insights into the Design of Synthetic Nanobody Libraries.
    Valdés-Tresanco MS; Molina-Zapata A; Pose AG; Moreno E
    Molecules; 2022 Mar; 27(7):. PubMed ID: 35408597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid and Sensitive Detection of Staphylococcal Enterotoxin B by Recombinant Nanobody Using Phage Display Technology.
    Zanganeh S; Rouhani Nejad H; Mehrabadi JF; Hosseini R; Shahi B; Tavassoli Z; Aramvash A
    Appl Biochem Biotechnol; 2019 Feb; 187(2):493-505. PubMed ID: 29984392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selection and characterization of camelid nanobodies towards urokinase-type plasminogen activator.
    Kaczmarek JZ; Skottrup PD
    Mol Immunol; 2015 Jun; 65(2):384-90. PubMed ID: 25749705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolation and characterization of nanobodies against epithelial cell adhesion molecule as novel theranostic agents for cancer therapy.
    Roshan R; Naderi S; Behdani M; Cohan RA; Ghaderi H; Shokrgozar MA; Golkar M; Kazemi-Lomedasht F
    Mol Immunol; 2021 Jan; 129():70-77. PubMed ID: 33183767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of single domain antibody fragments derived from camelids and generation of manifold constructs.
    Vincke C; Gutiérrez C; Wernery U; Devoogdt N; Hassanzadeh-Ghassabeh G; Muyldermans S
    Methods Mol Biol; 2012; 907():145-76. PubMed ID: 22907350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Construction of High-Quality Camel Immune Antibody Libraries.
    Romão E; Poignavent V; Vincke C; Ritzenthaler C; Muyldermans S; Monsion B
    Methods Mol Biol; 2018; 1701():169-187. PubMed ID: 29116505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Display Technologies for Generation of Ig Single Variable Domains.
    Bobkov V; van der Woning B; de Haard H
    Methods Mol Biol; 2018; 1827():129-144. PubMed ID: 30196495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single-domain antibodies: a versatile and rich source of binders for breast cancer diagnostic approaches.
    Even-Desrumeaux K; Fourquet P; Secq V; Baty D; Chames P
    Mol Biosyst; 2012 Sep; 8(9):2385-94. PubMed ID: 22772166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Construction of naïve camelids VHH repertoire in phage display-based library.
    Sabir JS; Atef A; El-Domyati FM; Edris S; Hajrah N; Alzohairy AM; Bahieldin A
    C R Biol; 2014 Apr; 337(4):244-9. PubMed ID: 24702893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of angiogenesis in human endothelial cell using VEGF specific nanobody.
    Kazemi-Lomedasht F; Behdani M; Bagheri KP; Habibi-Anbouhi M; Abolhassani M; Arezumand R; Shahbazzadeh D; Mirzahoseini H
    Mol Immunol; 2015 May; 65(1):58-67. PubMed ID: 25645505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanobodies and their potential applications.
    Hassanzadeh-Ghassabeh G; Devoogdt N; De Pauw P; Vincke C; Muyldermans S
    Nanomedicine (Lond); 2013 Jun; 8(6):1013-26. PubMed ID: 23730699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selection by phage display of nanobodies directed against hypoxia inducible factor-1α (HIF-1α).
    Li M; Fan X; Liu J; Hu Y; Huang H
    Biotechnol Appl Biochem; 2015; 62(6):738-45. PubMed ID: 25556956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel nanobody against urease activity of Helicobacter pylori.
    Ardekani LS; Gargari SL; Rasooli I; Bazl MR; Mohammadi M; Ebrahimizadeh W; Bakherad H; Zare H
    Int J Infect Dis; 2013 Sep; 17(9):e723-8. PubMed ID: 23561799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A guide to: generation and design of nanobodies.
    Muyldermans S
    FEBS J; 2021 Apr; 288(7):2084-2102. PubMed ID: 32780549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Construction of camelidae natural nanobody phage dispaly library and screening, production and identification of anti-CD19 nanobody].
    Li G; Li Y; Chu Y; Zhang A; Pan J; Wang H; Xu G
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Nov; 36(11):1036-1043. PubMed ID: 33210599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.